COVID-19 vaccines assessed for children 6 months and older

United States // 09 June, 2022

The FDA is expected to review vaccinations for children aged 6 months and older on 15 June.

Pfizer-BioNTech has submitted data to the FDA for approval of a three-dose primary series for children aged 6 months to 4 years old.

Moderna's two-dose primary series will be assessed for children 6 months to 5 years old.

Currently, children aged 5 and older can receive Pfizer-BioNTech's COVID-19 vaccine.

LATEST NEWS

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. …
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. …